Observational evaluation reveals quality of life outcomes in birdshot chorioretinitis patients aged 80 and older, highlighting the long-term disease impact.
Birdshot chorioretinitis (BSCR) is an ocular HLA-related disease with variable clinical progression. We examine the quality of life (QOL) of BSCR individuals aged ≥80 years, providing insights into the long-term disease impact.
No takes yet. Share an insight, caveat, or question.
Kaisari et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: